Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist von Willard, Francis S, Douros, Jonathan D, Gabe, Maria Bn, Showalter, Aaron D, Wainscott, David B, Suter, Todd M, Capozzi, Megan E, van der Velden, Wijnand Jc, Stutsman, Cynthia, Cardona, Guemalli R, Urva, Shweta, Emmerson, Paul J, Holst, Jens J, D'Alessio, David A, Coghlan, Matthew P, Rosenkilde, Mette M, Campbell, Jonathan E, Sloop, Kyle W

Volltext